Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03734666 · ClinicalTrials.gov registry record · NA

Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation

A NA study of Tobacco Use and Alcohol Use, Unspecified, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
NA
Development phase
67
Enrollment target
1
Study location

NCT03734666 is a NA study of Tobacco Use and Alcohol Use, Unspecified that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 67 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03734666, a NA study of Tobacco Use and Alcohol Use, Unspecified, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop a treatment that can effectively help people reduce their alcohol use and quit smoking.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy
  • BEHAVIORAL Mindfulness Based Relapse Prevention - Smoking and Alcohol

Study Locations (1)

Florida

  • H Lee Moffitt Cancer Center and Research Institute - Tampa

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2019-01-14
Est. Completion 2021-11-04
Phase NA

What the Registry Record Tells You About NCT03734666

The ClinicalTrials.gov registry entry for NCT03734666 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (82% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.

NCT03734666 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03734666 about?

NCT03734666 is a clinical study titled "Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation". The purpose of this study is to develop a treatment that can effectively help people reduce their alcohol use and quit smoking.

What is the current status of trial NCT03734666?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2019-01-14. Estimated completion is 2021-11-04.

What conditions does trial NCT03734666 study?

This clinical trial studies the following conditions: Tobacco Use, Alcohol Use, Unspecified.

What interventions are being tested in trial NCT03734666?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Mindfulness Based Relapse Prevention - Smoking and Alcohol (BEHAVIORAL).

Who is sponsoring clinical trial NCT03734666?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03734666 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.